FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802523009> ?p ?o ?g. }

• W2802523009 endingPage "22985" @default.
• W2802523009 startingPage "22976" @default.
• W2802523009 abstract "// Osama Mohamad 1, 2 , Reiko Imai 1 , Tadashi Kamada 1 , Yuki Nitta 1 , Nobuhito Araki 3 and the Working Group for Bone and Soft Tissue Sarcoma 1 Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan 2 University of Texas Southwestern Medical Center, Department of Radiation Oncology, Dallas, Texas, USA 3 Ashiya Municipal Hospital, 3 9-1 Asahigaoka, Ashiya City, Hyogo, Japan Correspondence to: Reiko Imai, email: Imai.Reiko@qst.go.jp Keywords: carbon ion; radiotherapy; charged particles; pediatric; osteosarcoma Received: January 20, 2018      Accepted: March 30, 2018      Published: May 01, 2018 ABSTRACT Background: Unresectable pediatric osteosarcoma has poor outcomes with conventional treatments. Results: Twenty-six patients aged 11–20 years (median 16) had inoperable osteosarcoma of the trunk (24 pelvic, 1 mediastinal and 1 paravertebral) without any other lesion at initial examination. There were 22 primary, 1 locally recurrent and 3 metastatic cases. Median CIRT dose was 70.4 Gy RBE (relative biological effectiveness) delivered in 16 fractions. Median follow-up was 32.7 months. Overall survival was 50.0% and 41.7% at 3 and 5 years, respectively. Ten patients survived for more than 5 years (range 5–20.7 years). Local control was 69.9% and 62.9% at 3 and 5 years, respectively and progression-free survival was 34.6% at 3 and 5 years. Only largest tumor diameter correlated with 5-year overall survival and local control. There were 4 grade 3-4 CIRT-related late toxicities, 1 case of bone fracture and no treatment-related mortalities. All patients (except 1) were able to ambulate after CIRT. Conclusions: CIRT was safe and efficacious in the treatment of inoperable pediatric osteosarcoma with improved local control and overall survival compared to conventional treatments. Methods: We retrospectively reviewed the records of pediatric and adolescent patients who received carbon ion radiotherapy (CIRT) for inoperable osteosarcoma between 1996 and 2014." @default.
• W2802523009 created "2018-05-17" @default.
• W2802523009 creator A5004763620 @default.
• W2802523009 creator A5012910042 @default.
• W2802523009 creator A5026510204 @default.
• W2802523009 creator A5036726875 @default.
• W2802523009 creator A5048882765 @default.
• W2802523009 date "2018-05-01" @default.
• W2802523009 modified "2023-10-02" @default.
• W2802523009 title "Carbon ion radiotherapy for inoperable pediatric osteosarcoma" @default.
• W2802523009 cites W1515150832 @default.
• W2802523009 cites W1600280574 @default.
• W2802523009 cites W1967903087 @default.
• W2802523009 cites W1975210359 @default.
• W2802523009 cites W1978858717 @default.
• W2802523009 cites W1982330508 @default.
• W2802523009 cites W1985983218 @default.
• W2802523009 cites W1988325237 @default.
• W2802523009 cites W1997533204 @default.
• W2802523009 cites W2000886562 @default.
• W2802523009 cites W2008700492 @default.
• W2802523009 cites W2013881151 @default.
• W2802523009 cites W2014055476 @default.
• W2802523009 cites W2016613877 @default.
• W2802523009 cites W2019607817 @default.
• W2802523009 cites W2020920713 @default.
• W2802523009 cites W2024838067 @default.
• W2802523009 cites W2049903086 @default.
• W2802523009 cites W2060367890 @default.
• W2802523009 cites W2067116365 @default.
• W2802523009 cites W2067707688 @default.
• W2802523009 cites W2070842831 @default.
• W2802523009 cites W2073945401 @default.
• W2802523009 cites W2080066814 @default.
• W2802523009 cites W2100975996 @default.
• W2802523009 cites W2101821854 @default.
• W2802523009 cites W2113485037 @default.
• W2802523009 cites W2118353907 @default.
• W2802523009 cites W2121769039 @default.
• W2802523009 cites W2128024099 @default.
• W2802523009 cites W2128052108 @default.
• W2802523009 cites W2143256090 @default.
• W2802523009 cites W2148077417 @default.
• W2802523009 cites W2153228211 @default.
• W2802523009 cites W2156511778 @default.
• W2802523009 cites W2265132046 @default.
• W2802523009 cites W2277536847 @default.
• W2802523009 cites W2285980177 @default.
• W2802523009 cites W2464390791 @default.
• W2802523009 cites W2518536370 @default.
• W2802523009 cites W4246742253 @default.
• W2802523009 doi "https://doi.org/10.18632/oncotarget.25165" @default.
• W2802523009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5955418" @default.
• W2802523009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29796166" @default.
• W2802523009 hasPublicationYear "2018" @default.
• W2802523009 type Work @default.
• W2802523009 sameAs 2802523009 @default.
• W2802523009 citedByCount "34" @default.
• W2802523009 countsByYear W28025230092018 @default.
• W2802523009 countsByYear W28025230092019 @default.
• W2802523009 countsByYear W28025230092020 @default.
• W2802523009 countsByYear W28025230092021 @default.
• W2802523009 countsByYear W28025230092022 @default.
• W2802523009 countsByYear W28025230092023 @default.
• W2802523009 crossrefType "journal-article" @default.
• W2802523009 hasAuthorship W2802523009A5004763620 @default.
• W2802523009 hasAuthorship W2802523009A5012910042 @default.
• W2802523009 hasAuthorship W2802523009A5026510204 @default.
• W2802523009 hasAuthorship W2802523009A5036726875 @default.
• W2802523009 hasAuthorship W2802523009A5048882765 @default.
• W2802523009 hasBestOaLocation W28025230091 @default.
• W2802523009 hasConcept C126838900 @default.
• W2802523009 hasConcept C142724271 @default.
• W2802523009 hasConcept C190892606 @default.
• W2802523009 hasConcept C2777760704 @default.
• W2802523009 hasConcept C2778256501 @default.
• W2802523009 hasConcept C2910615947 @default.
• W2802523009 hasConcept C2989005 @default.
• W2802523009 hasConcept C509974204 @default.
• W2802523009 hasConcept C71924100 @default.
• W2802523009 hasConceptScore W2802523009C126838900 @default.
• W2802523009 hasConceptScore W2802523009C142724271 @default.
• W2802523009 hasConceptScore W2802523009C190892606 @default.
• W2802523009 hasConceptScore W2802523009C2777760704 @default.
• W2802523009 hasConceptScore W2802523009C2778256501 @default.
• W2802523009 hasConceptScore W2802523009C2910615947 @default.
• W2802523009 hasConceptScore W2802523009C2989005 @default.
• W2802523009 hasConceptScore W2802523009C509974204 @default.
• W2802523009 hasConceptScore W2802523009C71924100 @default.
• W2802523009 hasIssue "33" @default.
• W2802523009 hasLocation W28025230091 @default.
• W2802523009 hasLocation W28025230092 @default.
• W2802523009 hasLocation W28025230093 @default.
• W2802523009 hasLocation W28025230094 @default.
• W2802523009 hasOpenAccess W2802523009 @default.
• W2802523009 hasPrimaryLocation W28025230091 @default.
• W2802523009 hasRelatedWork W1630209420 @default.
• W2802523009 hasRelatedWork W2031341258 @default.

• next